(Q43470740)

23 November 2017

title

The Soluble Receptor of Interleukin 2 is Not a Serum Marker of the Autoimmune Activity in Type I Diabetes Mellitus (English)

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

0 references

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

author name string

B. Vialettes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

N. Schmitt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

M. Hirn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

L. Hermitte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

S. Kaplanski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

C. Farnarier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

C. Mattei-Zevacco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

G. Simonin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

P. Vague

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1812996

1 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1812996

1 December 2022

publication date

1 January 1991

1 reference

full work available at URL

23 November 2017

http://www.tandfonline.com/doi/pdf/10.3109/08916939108994708

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

1 reference

23 November 2017

volume

11

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

53-59

1 reference

Anti-interleukin 2 receptor antibody attenuates low-dose streptozotocin-induced diabetes in mice

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Interleukin 2 and soluble interleukin 2-receptor secretion defect in vitro in newly diagnosed type I diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Developmental regulation of serum interleukin-2 receptor concentrations: attenuation of the childhood peak in patients at risk for developing or having recently developed type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Soluble interleukin-2 receptors in the serum of patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916939108994708

Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetes

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

2

30

902

Signore A

1987

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

1 December 2022

5

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

Federation Proceedings

10

45

454

Mackeen L

1986

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Plasma interleukin 2 receptor levels in renal allograft recipients

1 December 2022

12

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Plasma interleukin 2 receptor levels in renal allograft dysfunction

1 December 2022

13

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients

1 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Soluble interleukin-2 receptors in serum and bile of liver transplant recipients

1 December 2022

15

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity?

1 December 2022

17

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Effect of cyclosporin on interleukin 2-related T-lymphocyte parameters in IDDM patients

1 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

How, when, and why to predict IDDM

1 December 2022

24

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Low acute insulin response to intravenous glucose. A sensitive but non-specific marker of early stages of type 1 (insulin-dependent) diabetes

1 December 2022

26

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

Federation Proceedings

28

45

378

Saadeh C

1986

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Lymphocyte subsets and activation in prediabetes

1 December 2022

31

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Culture and Phenotype of Activated T-Cells from Patients with Type I Diabetes Mellitus

1 December 2022

32

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins

1 December 2022

33

1 reference

https://api.crossref.org/works/10.3109/08916939108994708

1 December 2022

Identifiers

1 reference

23 November 2017

1 reference